Ardiente, Emerita A.

HRN: 26-54-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/19/2025
01/26/2025
IV
300mg
Q6h
DFI
Waiting Final Action 
01/19/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/19/2025
01/26/2025
IV
4.5 LD Then 2.25gm
Q8h
DFI, Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: